Putins China Visit Signals Deeper Economic Ties Market Implications Ahead Nutanix NTNX Q1 2026 Earnings EPS 056 Beats Estimates Miller Industries MLR Q1 2026 Earnings Miss Sparks Concern EU to Slash Growth Forecasts Hike Inflation Outlook Amid Iran Conflict Stagflation Fears Fed Cut Hopes Dim as Jobs Data Underscore Sticky Inflation PL Capital Highlights Growth Potential in Adani Group Stocks Smallcase Managers Forecast Nifty 50 Could Reach 2800030000 by FY27 Amid 9 YTD Decline Middle East Conflict Challenges Gulfs AI Hub Ambitions as Data Center Attacks and Energy Costs Rise Chinas Crypto Crackdown Faces Persistent Evasion by Middlemen Court Cases Show Investors Flock to HALO Stocks as Market Searches for Sectors Beyond AIs Reach FMBH Q1 2026 Earnings EPS Beats Estimates by 531 as Shares Rise RXST Q1 2026 Earnings EPS Misses Estimates Amid Ongoing RampUp AMTM Q1 2026 Earnings EPS Beats Estimates by 26 Revenue Details Not Reported SYF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Franklin BSP Realty Trust Inc FBRT Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Climate MTD Q1 2026 Earnings EPS Surpasses Estimates Despite Limited Revenue Disclosure Cuprina Holdings CUPR Slides 9 Key Support Levels Under Pressure Gabelli MultiMedia Trust GGT Edges Higher as Price Holds Above Support Cross Country Healthcare CCRN Holds Steady at 1305 as Shares Consolidate Near Support CDT Equity Inc CDT Plunges 14 as Selling Pressure Intensifies Below 110 Resistance Western Alliance Bancorporation Holds Steady Near 7859 as Consolidation Continues Qorvo Insider Filing Signals Potential Stock Sale Activity Proto Labs PRLB Q1 2026 Earnings Surprise EPS 054 Up Significant Xi Warns Trump on Taiwan USChina Relations Face Great Jeopardy at Beijing Summit NYT Strands Puzzle for May 14 Unveils Men in Tights Theme Hints and Answers Released Faisal Islam Six Things We Now Know About the UK Economy in Charts Mercury Fintech Achieves 52 Billion Valuation Following 200 Million Funding Round Pulmonx LUNG Q1 2026 Earnings Narrower Loss Beats Estimates as Stock Edges Higher Nektar Therapeutics NKTR Slips 128 as Shares Approach Key Support Level